Delivery Order SPE2DB22D1017-SPE2DB24FG3AR

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $7,659.43. The contract is a firm fixed price, non-set-aside contract with a period of performance ending on June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $3,799.17 and a period of performance through September 11, 2024. This is not a set-aside contract. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) from DLA and other federal agencies, valued up to $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with a ceiling value of $6,774.14 and a completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,782.76 firm fixed-price contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication, with a completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for ELIQUIS 5 MG TABLET 60S. The order has a ceiling value of $1,923.56 and a completion date of May 22, 2024. The contract is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,390.95 firm-fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $16,202.95 and a period of performance ending on August 16, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 and runs through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,221.47 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication, with a ceiling value of $7,418.61. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,499.49 firm fixed-price delivery order is for the supply of 4564528108 - ELIQUIS 5 MG TABLET 60S, with an ultimate completion date of May 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3AR
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a total ceiling value of $3,764.16 and is set to expire on August 13, 2024.

Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which serve as primary vehicles for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives. This specific delivery order is likely part of a larger IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, that enables the DLA to efficiently procure essential medical commodities from Amerisourcebergen.

The contract does not have a set-aside designation, indicating it was competed on an unrestricted basis. There is no information provided about major subcontractors.

Generated 11/11/24, 9:16 AM